• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰抑制素抑制大鼠脂肪细胞中的胰岛素作用。

Pancreastatin inhibits insulin action in rat adipocytes.

作者信息

Sánchez-Margalet V, González-Yanes C

机构信息

Department of Medical Biochemistry and Molecular Biology, School of Medicine, Investigation Unit of the University Hospital Virgen Macarena, Seville 41009, Spain.

出版信息

Am J Physiol. 1998 Dec;275(6):E1055-60. doi: 10.1152/ajpendo.1998.275.6.E1055.

DOI:10.1152/ajpendo.1998.275.6.E1055
PMID:9843749
Abstract

Pancreastatin (PST), a regulatory peptide with a general inhibitory effect on secretion, is derived from chromogranin A, a glycoprotein present throughout the neuroendocrine system. We have previously demonstrated the counterregulatory role of PST on insulin action in rat hepatocytes. Here, we are reporting the PST effects on rat adipocytes. PST dose dependently inhibits basal and insulin-stimulated glucose transport, lactate production, and lipogenesis, impairing the main metabolic actions of insulin in adipocytes. These effects were observed in a wide range of insulin concentrations, leading to a shift to the right in the dose-response curve. Maximal effect was observed at 10 nM PST, and the IC50 value was approximately 1 nM. Moreover, PST has a lipolytic effect in rat adipocytes (ED50 0.1 nM), although it was completely inhibited by insulin. In contrast, PST dose dependently stimulated protein synthesis and enhanced insulin-stimulated protein synthesis. In summary, these data show the lipokinetic effect of PST and the inhibitory effect of PST on insulin metabolic action within a range of physiological concentrations. Therefore, these results give new pathophysiological basis for the association of PST with insulin resistance.

摘要

胰抑制素(PST)是一种对分泌具有普遍抑制作用的调节肽,它由嗜铬粒蛋白A衍生而来,嗜铬粒蛋白A是一种存在于整个神经内分泌系统中的糖蛋白。我们之前已经证明了PST在大鼠肝细胞中对胰岛素作用的反调节作用。在此,我们报告PST对大鼠脂肪细胞的影响。PST剂量依赖性地抑制基础和胰岛素刺激的葡萄糖转运、乳酸生成及脂肪生成,损害胰岛素在脂肪细胞中的主要代谢作用。在广泛的胰岛素浓度范围内均观察到了这些效应,导致剂量反应曲线向右移动。在10 nM PST时观察到最大效应,IC50值约为1 nM。此外,PST对大鼠脂肪细胞具有脂解作用(ED50为0.1 nM),尽管它被胰岛素完全抑制。相反,PST剂量依赖性地刺激蛋白质合成并增强胰岛素刺激的蛋白质合成。总之,这些数据显示了PST在生理浓度范围内的脂肪动力学效应以及对胰岛素代谢作用的抑制作用。因此,这些结果为PST与胰岛素抵抗的关联提供了新的病理生理学基础。

相似文献

1
Pancreastatin inhibits insulin action in rat adipocytes.胰抑制素抑制大鼠脂肪细胞中的胰岛素作用。
Am J Physiol. 1998 Dec;275(6):E1055-60. doi: 10.1152/ajpendo.1998.275.6.E1055.
2
Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.胰抑制素是一种源自嗜铬粒蛋白A的肽,它通过激活大鼠脂肪细胞中的糖原合成酶激酶3来抑制胰岛素刺激的糖原合成。
Biochem Biophys Res Commun. 2001 Nov 23;289(1):282-7. doi: 10.1006/bbrc.2001.5967.
3
Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes.胰抑素是一种源自嗜铬粒蛋白A的肽,可激活大鼠脂肪细胞中的蛋白质合成信号级联反应。
Biochem Biophys Res Commun. 2002 Dec 13;299(4):525-31. doi: 10.1016/s0006-291x(02)02682-7.
4
Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk.胰抑制素调节大鼠脂肪细胞中的胰岛素信号传导:相互作用机制
Diabetes. 2000 Aug;49(8):1288-94. doi: 10.2337/diabetes.49.8.1288.
5
Pancreastatin is an endogenous peptide that regulates glucose homeostasis.胰淀素是一种内源性肽,可调节葡萄糖稳态。
Physiol Genomics. 2013 Nov 15;45(22):1060-71. doi: 10.1152/physiolgenomics.00131.2013. Epub 2013 Sep 24.
6
Characterization of pancreastatin receptors and signaling in adipocyte membranes.脂肪细胞膜中胰抑制素受体及信号传导的特性研究
Biochim Biophys Acta. 1999 Aug 12;1451(1):153-62. doi: 10.1016/s0167-4889(99)00084-1.
7
Pancreastatin, a chromogranin A-derived peptide, inhibits leptin and enhances UCP-2 expression in isolated rat adipocytes.胰抑制素是一种源自嗜铬粒蛋白A的肽,它可抑制瘦素并增强分离的大鼠脂肪细胞中解偶联蛋白2(UCP-2)的表达。
Cell Mol Life Sci. 2003 Dec;60(12):2749-56. doi: 10.1007/s00018-003-3346-7.
8
Glucose-dependent effects of pancreastatin on insulin and glucagon release.胰抑制素对胰岛素和胰高血糖素释放的葡萄糖依赖性作用。
Int J Pancreatol. 1991 Oct;10(2):143-9. doi: 10.1007/BF02924117.
9
Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes.胰抑制素抑制大鼠肝细胞中胰岛素刺激的糖原合成,但不抑制糖酵解。
Regul Pept. 1994 May 26;51(3):215-20. doi: 10.1016/0167-0115(94)90067-1.
10
Effects of pancreastatin and somatostatin on secretagogues-induced rise in intracellular free calcium in single rat pancreatic islet cells.胰抑制素和生长抑素对大鼠单个胰岛细胞中促分泌剂诱导的细胞内游离钙升高的影响。
Regul Pept. 1996 Feb 22;61(2):143-8. doi: 10.1016/0167-0115(95)00160-3.

引用本文的文献

1
Inflammation Promotes Proteolytic Processing of the Prohormone Chromogranin A by Macrophages.炎症促进巨噬细胞对前激素嗜铬粒蛋白A的蛋白水解加工。
J Endocr Soc. 2025 May 15;9(7):bvaf090. doi: 10.1210/jendso/bvaf090. eCollection 2025 Jul.
2
Main mechanisms and clinical implications of alterations in energy expenditure state among patients with pheochromocytoma and paraganglioma: A review.原发性嗜铬细胞瘤和副神经节瘤患者能量消耗状态改变的主要机制及临床意义:综述。
Medicine (Baltimore). 2024 Apr 26;103(17):e37916. doi: 10.1097/MD.0000000000037916.
3
NADPH Oxidase 3: Beyond the Inner Ear.
NADPH氧化酶3:内耳之外
Antioxidants (Basel). 2024 Feb 8;13(2):219. doi: 10.3390/antiox13020219.
4
Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis.嗜铬粒蛋白 A 及其衍生肽:胆固醇动态平衡的潜在调节剂。
Cell Mol Life Sci. 2023 Aug 29;80(9):271. doi: 10.1007/s00018-023-04908-3.
5
The immunomodulatory functions of chromogranin A-derived peptide pancreastatin.嗜铬粒蛋白 A 衍生肽胰淀素的免疫调节功能。
Peptides. 2022 Dec;158:170893. doi: 10.1016/j.peptides.2022.170893. Epub 2022 Oct 13.
6
Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months.小于胎龄儿的差异DNA甲基化谱:与出生至24个月龄时肥胖和胰岛素抵抗标志物的关联
BMJ Open Diabetes Res Care. 2020 Oct;8(1). doi: 10.1136/bmjdrc-2020-001402.
7
Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.嗜铬粒蛋白 A 及其片段在心血管、免疫代谢和癌症调控中的作用。
Ann N Y Acad Sci. 2019 Nov;1455(1):34-58. doi: 10.1111/nyas.14249. Epub 2019 Oct 6.
8
Chromogranin A: its known and possible roles in obstetrics and gynecology.嗜铬粒蛋白A:其在妇产科已知及可能的作用
Dev Period Med. 2018;22(4):297-300. doi: 10.34763/devperiodmed.20182204.297300.
9
Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus.发现用于治疗胰岛素抵抗和糖尿病的胰抑素抑制剂 PSTi8:在糖尿病啮齿动物模型中的研究。
Sci Rep. 2018 Jun 7;8(1):8715. doi: 10.1038/s41598-018-27018-8.
10
Chromogranins: from discovery to current times.嗜铬粒蛋白:从发现到现在。
Pflugers Arch. 2018 Jan;470(1):143-154. doi: 10.1007/s00424-017-2027-6. Epub 2017 Sep 5.